Powerful medicines that enlist the
immune system to fight cancer can, in rare cases, cause damage to the heart,
according to some doctors. So far, less than 1% of patients taking these
medicines – called checkpoint inhibitors 0- have developed heart trouble. But in
those who do, the damage can be severe, and the drugs have led to several
deaths by provoking the immune system to attack the heart. The risk appears highest
when patients take two different checkpoint inhibitors at once. This is new complication
of potentially lifesaving drugs. Four checkpoint inhibitors are in the market:
ipilimumab (brand name Yervou), nivolumab (Opdivo), pembrolizumab (Keytruda)
and zolizumab (Tecentriq). The side effects have prompted hospitals to add
extra cardiac testing for patients taking more than one drug.
Friday, 11 November 2016
Psychiatric Drugs Prevent Return To Crime
Giving psychiatric drugs to
ex-prisoners can lead to a huge reduction in reoffending, according to a new
study in Sweden. The treatment can help make those given to violence more
pacified and allow people to adjust easily to life outside of confinement. The research
looked at prisoners from across Sweden who were released between 2005 and 2010,
and watched their progress until the end of 2013. The study looked at 22,275
former inmates and sound that 4,031 of them committed violent offences during
the period. Treatment with antipsychotic drugs saw a 42% fall in the rate of violent
reoffending. Treatment with psychostimulants led to a 36% drop and drugs used
to help with addictive disorders cut to assaults by more than half.
Subscribe to:
Comments (Atom)

